- Home
- ATHA vs EJH Comparison
ATHA vs EJH Comparison
Compare ATHA & EJH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATHA | EJH |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.2M | 17.0M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ATHA | EJH |
|---|---|---|
| Price | $3.87 | $0.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.1K | ★ 93.3K |
| Earning Date | 11-06-2025 | 12-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $49,402,956.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.20 | $0.74 |
| 52 Week High | $6.18 | $64.00 |
Technical Indicators
Market Signals| Indicator | ATHA | EJH |
|---|---|---|
| Relative Strength Index (RSI) | 40.18 | 38.70 |
| Support Level | $3.84 | $0.78 |
| Resistance Level | $4.34 | $0.87 |
| Average True Range (ATR) | 0.27 | 0.06 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 5.98 | 10.93 |
Price Performance
Historical ComparisonAbout ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About EJH E-Home Household Service Holdings Limited
E-Home Household Service Holdings Ltd is a household service company providing integrated household services through its website and WeChat platform across China. The company offers services including home appliance and housekeeping services. It operates its business mainly by receiving orders online and providing services offline. Its operations are organized into four reportable segments: appliance installation and maintenance services, housekeeping services, senior care services, and educational consulting services. The company generates the majority of its revenue from installation and maintenance.